| ASRYX | CSFZX | ASRYX / CSFZX | |
| Total Expense Ratio | 1.01 | 0.84 | 120% |
| Annual Report Gross Expense Ratio | 1.01 | 0.84 | 120% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 6.337 | 8.906 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 405M | 2.06B | 20% |
| Annual Yield % from dividends | 3.36 | 2.84 | 118% |
| Returns for 1 year | 2.36 | 2.55 | 92% |
| Returns for 3 years | 16.24 | 20.56 | 79% |
| Returns for 5 years | 13.66 | 19.37 | 71% |
| Returns for 10 years | 29.50 | 48.09 | 61% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CGFAX | 84.71 | 0.45 | +0.53% |
| American Funds Growth Fund of Amer 529A | |||
| MECVX | 16.01 | 0.02 | +0.13% |
| NYLI Epoch Capital Growth Investor Class | |||
| SAGAX | 57.00 | N/A | N/A |
| Virtus Zevenbergen Innovative Gr Stk A | |||
| AWAAX | 24.26 | N/A | N/A |
| AB Wealth Appreciation Strategy A | |||
| JENRX | 42.37 | N/A | N/A |
| Jensen Quality Growth R | |||